Overview

Brugada (brew-GAH-dah) syndrome is a rare heart rhythm condition. It can cause the heart to beat very fast and in an uneven way. These irregular heartbeats are called arrhythmias. Brugada syndrome usually runs in families, which means it's inherited. It's often linked to changes in genes.

People with Brugada syndrome have a higher risk of a dangerously fast and uneven heartbeat called ventricular fibrillation (VFib). VFib is a medical emergency. It needs treatment right away. Without treatment, it can cause sudden cardiac death.

Treatment for Brugada syndrome depends on your risk of serious irregular heartbeats such as VFib. Some people without symptoms of Brugada syndrome may not need treatment. Others may need medicines, a heart procedure or a device called an implantable cardioverter-defibrillator (ICD).

If you have Brugada syndrome, you need to stay away from things that can trigger irregular heartbeats. For example, it's important to quickly lower a fever and not use some medicines.


Symptoms

Many people with Brugada syndrome have no symptoms. When symptoms occur, they may be related to a dangerously fast heartbeat.

Symptoms of Brugada syndrome may include:

  • Fainting.
  • Fast, fluttering or pounding heartbeats, called palpitations.
  • Gasping or difficult breathing during sleep.
  • Seizures.

If you have symptoms of Brugada syndrome, you may be referred to a heart rhythm specialist.


When to seek care

Make an appointment with a healthcare professional if you have fainting, palpitations or other symptoms that could be related to a heart rhythm condition. Testing can help find the cause.

Talk with your healthcare team if a parent, sibling or child has Brugada syndrome. You may need testing even if you don't have symptoms.


When to seek emergency care

Call 911 or your local emergency number if you faint and may be having a dangerous heartbeat. Get emergency help for sudden cardiac arrest or symptoms of a life-threatening heartbeat. 


Causes

The heart's electrical system controls the heartbeat. The heart's electrical signals tell the heart when to squeeze and relax so it can pump blood. The signals start in a group of cells at the top of the heart called the sinus node. They travel through a pathway between the upper and lower heart chambers called the atrioventricular (AV) node. The timing of the signals is what creates a steady heartbeat and lets the heart pump blood.

In a healthy heart, this signaling process usually goes smoothly. But in Brugada syndrome, changes in the heart's electrical signals can lead to dangerous heartbeats in the heart's lower chambers. An example is ventricular fibrillation (VFib). Without treatment right away, VFib can cause sudden cardiac arrest or sudden cardiac death.

Brugada syndrome is linked to changes in genes. The condition can be passed down in families, but the way it is inherited is complex. Changes in a gene called SCN5A are the best-known genetic cause of Brugada syndrome.

In many people with Brugada syndrome, genetic testing doesn't find a disease-causing change in the SCN5A gene. This type of gene change is found in about 20% to 25% of people with Brugada syndrome.

Some medicines can cause changes on a test called an electrocardiogram (ECG or EKG) that can look like Brugada syndrome. An ECG records the electrical signals that make the heart beat. The results appear as lines and waves called a tracing. The shape of the tracing gives your healthcare team information about the heart's electrical activity. Medicines called sodium channel blockers can cause a type 1 Brugada pattern to appear. In a type 1 pattern, part of the ECG tracing rises and then slopes down in a curved shape. 

If medicine causes a type 1 pattern, your healthcare team looks at the pattern along with symptoms, family history and other information when diagnosing Brugada syndrome.

Some antidepressants also may cause Brugada pattern changes.


Risk factors

Risk factors for Brugada syndrome include:

  • Family history of Brugada syndrome. Brugada syndrome can be passed down in families. Having a close family member with Brugada syndrome may raise your risk of having the condition.
  • Being male. Brugada syndrome is more common in males than in females.
  • Asian background. Brugada syndrome is more common in people with an Asian background.
  • Fever. A fever doesn't cause Brugada syndrome. But it can affect the heart and trigger an irregular heartbeat that can cause fainting or sudden cardiac arrest in people with Brugada syndrome.
  • Some medicines. Some medicines can cause a type 1 Brugada pattern or trigger ventricular fibrillation. Ask your healthcare team which medicines to avoid. Always tell your healthcare team about all the medicines you take. Include those you buy without a prescription.
  • Alcohol use. Drinking a lot of alcohol can trigger ventricular fibrillation and sudden cardiac arrest in some people with Brugada syndrome.
  • Cannabis and cocaine use. Cannabis and cocaine may cause changes on an ECG that look like Brugada syndrome. Tetrahydrocannabinol (THC), the main mind-altering ingredient in cannabis, also may trigger dangerous heartbeats in people with Brugada syndrome.

Complications

Complications of Brugada syndrome include:

  • Ventricular fibrillation. This is a dangerously fast and uneven heartbeat that can cause sudden cardiac arrest. VFib needs emergency medical care. If you have Brugada syndrome and faint, get medical help right away. Fainting can be a symptom of VFib.
  • Sudden cardiac arrest. This is the sudden loss of heart function, breathing and consciousness. Emergency treatment is needed right away to prevent sudden cardiac death.

Prevention

If you have Brugada syndrome, taking steps to avoid certain triggers can help lower your risk of dangerous heartbeats. 

If someone in your family has Brugada syndrome, talk with your healthcare team about genetic testing. Genetic testing can help you learn if you have a gene change linked to Brugada syndrome. 


Sept 21, 2026

  1. Behr ER, et al. The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: A clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. 2025; doi:10.1093/europace/euaf067.
  2. Viskin S, et al. Diagnosis of Brugada syndrome with a sodium-channel-blocker test: Who should be tested? Who should not? Circulation. 2024; doi:10.1161/CIRCULATIONAHA.124.069138.
  3. Zeppenfeld K, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal. 2022; doi:10.1093/eurheartj/ehac262.
  4. Gaita F, et al. Asymptomatic patients with Brugada ECG pattern: Long-term prognosis from a large prospective study. Circulation. 2023; doi:10.1161/CIRCULATIONAHA.123.064689.
  5. Doundoulakis I, et al. SCN5A gene variants and arrhythmic risk in Brugada syndrome: An updated systematic review and meta-analysis. Heart Rhythm. 2024; doi:10.1016/j.hrthm.2024.04.047.
  6. Pannone L, et al. Genetic testing in Brugada syndrome: A 30-year experience. Circulation: Arrhythmia and Electrophysiology. 2024; doi:10.1161/CIRCEP.123.012374.
  7. Gaita F, et al. Brugada syndrome: Identification of subjects at risk and therapy. European Heart Journal Supplements. 2024; doi:10.1093/eurheartjsupp/suae021.
  8. Seri A, et al. Vaping tetrahydrocannabinol unmasks Brugada pattern and induces ventricular fibrillation in Brugada syndrome: A case report. European Heart Journal — Case Reports. 2022; doi:10.1093/ehjcr/ytac200.
  9. Kim JH, et al. Clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities: A scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2025; doi:10.1161/CIR.0000000000001297.
  10. AskMayoExpert. Brugada syndrome. Mayo Clinic; 2025.
  11. Gaita F, et al. The Brugada syndrome: Risk stratification. European Heart Journal Supplements. 2023; doi:10.1093/eurheartjsupp/suad035.
  12. Borrell-Vega J, et al. Eighteen-year analysis of anaesthetic management in Brugada syndrome: The BRUGANAES study. European Journal of Anaesthesiology. 2025; doi:10.1097/EJA.0000000000002146.
  13. Alexander J, et al. Wellens syndrome: An important consideration in patients with chest pain. Journal of the American Academy of Physician Associates. 2023; doi:10.1097/01.JAA.0000911188.18646.31.
  14. How the heart works: How the heart beats. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/heart/heart-beats. Accessed Aug. 25, 2026.
  15. American Heart Association. Electrophysiology studies. https://www.heart.org/en/health-topics/arrhythmia/symptoms-diagnosis--monitoring-of-arrhythmia/electrophysiology-studies. Accessed Aug. 26, 2026.
  16. Scherr D, et al. Same-day discharge after electrophysiological and cardiac implantable electronic device procedures: A clinical consensus statement of the European Heart Rhythm Association (EHRA) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC. Europace. 2026; doi:10.1093/europace/euag065.
  17. Al-Khatib SM, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018; doi:10.1161/CIR.0000000000000549.

CON-20370473

Fuel groundbreaking medical research!

Your donation powers the future of medicine and helps save lives.